Incidence and contributors to potential drug-drug interactions in hospitalized patients

Journal of Clinical Pharmacology

Volumn 51, Issue 7, 2011, Pages 1043-1050

  Reimche, Leanne ^a   Forster, Alan J ^a,b,c   Van Walraven, Carl ^a,b,c,d  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d NONE   (Canada)

Author keywords

biostats clinical trials; Clinical research; epidemiology; outcomes research; pharmacoepidemiology

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIPYRETIC AGENT; BENZODIAZEPINE; CLARITHROMYCIN; DIGOXIN; DIURETIC AGENT; FUROSEMIDE; GLIBENCLAMIDE; GLYCERYL TRINITRATE; HEPARIN; HISTAMINE H2 RECEPTOR ANTAGONIST; LAXATIVE; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE AGONIST; POTASSIUM CHLORIDE; RIFABUTIN; SILDENAFIL; SPIRONOLACTONE; WARFARIN;

ADULT; AGE; AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DRUG DRUG INTERACTION; DRUG EXPOSURE; DRUG INTERACTION; FEMALE; GENDER; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; PATIENT CARE; RETROSPECTIVE STUDY;

ADULT; AGE FACTORS; AGED; COHORT STUDIES; DRUG INTERACTIONS; DRUG PRESCRIPTIONS; DRUG TOXICITY; FEMALE; HOSPITALIZATION; HOSPITALS, TEACHING; HUMANS; INCIDENCE; LENGTH OF STAY; MALE; MIDDLE AGED; ONTARIO; POISSON DISTRIBUTION; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 79958858786     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270010378858     Document Type: Article

References (30)

1. Making Health Care Safer: A Critical Analysis of Patient Safety Practices. Shojania KG Duncan BW McDonald KM Wachter RM, ed. Rockville, MD: Agency for Healthcare Research and Quality ; 2001 :
2. Baker GR, Norton PG, Flintoft V, et al. The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada. CMAJ. 2004 ; 170: 1678-1686 (Pubitemid 38758745)
3. To Err is Human: Building a Safer Health System. Kohn LT Corrigan JM Molla SD, ed. Washington, DC: National Academy Press ; 2000 :
4. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998 ; 279: 1200-1205 (Pubitemid 28193431)
5. Bates DW, Boyle DL, Vander Vliet MB, Schneider J, Leape L. Relationship between medication errors and adverse drug events. J Gen Intern Med. 1995 ; 10: 199-205
6. Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA. 1997 ; 277: 307-311 (Pubitemid 27045011)
7. Burleson KW. Review of computer applications in institutional pharmacy: 1975-1981. Am J Hosp Pharm. 1982 ; 39: 53-70 (Pubitemid 12177466)
8. Greenlaw CW, Zellers DD. Computerized drug-drug interaction screening system. Am J Hosp Pharm. 1978 ; 35: 567-570 (Pubitemid 8336390)
9. Hood JC, Miller JR. Use of computer drug-drug interaction program for detection of adverse drug reactions and related therapeutic problems. Drug Intell Clin Pharm. 1979 ; 13: 774-777 (Pubitemid 10118577)
10. McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother. 2002 ; 36: 1331-1336 (Pubitemid 34925265)
11. Gosney M, Tallis R. Prescription of contraindicated and interacting drugs in elderly patients admitted to hospital. Lancet. 1984 ; 2: 564-567 (Pubitemid 14072066)
12. Herr RD, Caravati EM, Tyler LS, Iorg E, Linscott MS. Prospective evaluation of adverse drug interactions in the emergency department. Ann Emerg Med. 1992 ; 21: 1331-1336
13. Huic M, Mucolic V, Vrhovac B, Francetic I, Bakran I, Giljanovic S. Adverse drug reactions resulting in hospital admission. Int J Clin Pharmacol Ther. 1994 ; 32: 675-682 (Pubitemid 24365689)
14. Karas S. The potential for drug interactions. Ann Emerg Med. 1981 ; 10: 627-630
15. Wiltink EH. Medication control in hospitals: a practical approach to the problem of drug-drug interactions. Pharm World Sci. 1998 ; 20: 173-177 (Pubitemid 28393872)
16. Drug Interactions Analysis and Management. Hansten PD Horn JR, ed. St. Louis, MO: Wolters Kluwer Health ; 2005 :
17. Straubhaar B, Krahenbuhl S, Schlienger RG. The prevalence of potential drug-drug interactions in patients with heart failure at hospital discharge. Drug Saf. 2006 ; 29: 79-90 (Pubitemid 43213897)
18. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987 ; 40: 373-383 (Pubitemid 17055592)
19. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005 ; 43: 1130-1139 (Pubitemid 41587600)
20. Schneeweiss S, Wang PS, Avorn J, Glynn RJ. Improved comorbidity adjustment for predicting mortality in Medicare populations. Health Serv Res. 2003 ; 38: 1103-1120 (Pubitemid 37048302)
21. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999 ; 341: 709-717 (Pubitemid 29407370)
22. Patetta M SAS Institute Inc ; 2005 :
23. Durrence CW, DiPiro JT, May JR, Nesbit RR, Sisley JF, Cooper JW. Potential drug interactions in surgical patients. Am J Hosp Pharm. 1985 ; 42: 1553-1556 (Pubitemid 15041691)
24. Beers MH, Storrie M, Lee G. Potential adverse drug interactions in the emergency room. An issue in the quality of care. Ann Intern Med. 1990 ; 112: 61-64 (Pubitemid 20026369)
25. Blix HS, Viktil KK, Reikvam A, et al. The majority of hospitalized patients have drug-related problems: results from a prospective study in general hospitals. Eur J Clin Pharmacol. 2004 ; 60: 651-658 (Pubitemid 40064598)
26. Mannesse CK, Derkx FH, de Ridder MA, Man in't Veld AJ, van der Cammen TJ. Contribution of adverse drug reactions to hospital admission of older patients. Age Aging. 2000 ; 29: 35-39 (Pubitemid 30055061)
27. Buajordet I, Ebbesen J, Erikssen J, Brors O, Hilberg T. Fatal adverse drug events: the paradox of drug treatment. J Intern Med. 2001 ; 250: 327-341 (Pubitemid 32955618)
28. Chen YF, Avery AJ, Neil KE, Johnson C, Dewey ME, Stockley IH. Incidence and possible causes of prescribing potentially hazardous/contraindicated drug combinations in general practice. Drug Saf. 2005 ; 28: 67-80
29. Egger T, Dormann H, Ahne G, et al. Identification of adverse drug reactions in geriatric inpatients using a computerised drug database. Drugs Aging. 2003 ; 20: 769-776 (Pubitemid 36995253)
30. Juurlink DN, Mamdani M, Kopp A, Laupacis A, Redelmeier DA. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA. 2003 ; 289: 1652-1658 (Pubitemid 37430270)